More weight-loss drugs could be offered as part of new diabetes care

NICE recommends more personalized care for 2 diabetes patients in the UK, suggesting the use of newer medicines, including weight-loss drugs, to prevent complications like heart disease and strokes. Around 2.3 million people could benefit from SGLT-2 inhibitors, which can save lives and reduce NHS costs. NICE urges a shift towards personalized treatment to improve outcomes and reduce disparities in medication access across different demographics, emphasizing the potential health benefits and cost savings associated with wider prescription of these drugs.